Animalcare Group PLC (GB:ANCR)
LSE:ANCR

Animalcare (ANCR) Share Price & Analysis

2 Followers

ANCR Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range143.08p - 278.02p
Previous Close185p
Volume18.80K
Average Volume (3M)61.07K
Market Cap
£111.18M
Enterprise Value11.66B
Total Cash (Recent Filing)£6.04M
Total Debt (Recent Filing)£11.44M
Price to Earnings (P/E)95.9
Beta0.26
Mar 26, 2024
EPS EstimateN/A
0.03 (0.02%)
Share Statistics
EPS (TTM)0.02
Shares Outstanding60,092,161
10 Day Avg. Volume28,685
30 Day Avg. Volume61,066
Standard Deviation0.09
R-Squared0.04
Alpha0.00384
Financial Highlights & Ratios
Price to Book (P/B)3683.85
Price to Sales (P/S)351.57
Price to Cash Flow (P/CF)685.30
P/FCF Ratio720.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

ANCR FAQ

What was Animalcare Group PLC’s price range in the past 12 months?
Animalcare Group PLC lowest share price was 143.08p and its highest was 278.02p in the past 12 months.
    What is Animalcare Group PLC’s market cap?
    Currently, no data Available
    When is Animalcare Group PLC’s upcoming earnings report date?
    Animalcare Group PLC’s upcoming earnings report date is Mar 26, 2024 which is in 180 days.
      How were Animalcare Group PLC’s earnings last quarter?
      Animalcare Group PLC released its earnings results on Sep 26, 2023. The company reported 0.027p earnings per share for the quarter, beating the consensus estimate of N/A by 0.027p.
        Is Animalcare Group PLC overvalued?
        According to Wall Street analysts Animalcare Group PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Animalcare Group PLC pay dividends?
          Animalcare Group PLC pays a Annually dividend of 2.4p which represents an annual dividend yield of 2.38%. See more information on Animalcare Group PLC dividends here
            What is Animalcare Group PLC’s EPS estimate?
            Animalcare Group PLC’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Animalcare Group PLC have?
            Animalcare Group PLC has 60,097,622 shares outstanding.
              What happened to Animalcare Group PLC’s price movement after its last earnings report?
              Animalcare Group PLC reported an EPS of 0.027p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.37%.
                Which hedge fund is a major shareholder of Animalcare Group PLC?
                Currently, no hedge funds are holding shares in GB:ANCR

                ---

                Animalcare Stock Smart Score

                2
                Underperform
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -31.82%
                12-Months-Change

                Fundamentals

                Return on Equity
                1.45%
                Trailing 12-Months
                Asset Growth
                -2.36%
                Trailing 12-Months
                The Animalcare Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Animalcare Group PLC

                Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is one of the leading generic veterinary medicines companies. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. Its only reportable segment is Pharmaceutical which includes the development and marketing of innovative pharmaceutical products. The company has a presence in Belgium, Spain, Portugal, the United Kingdom, and Other Countries of which Spain derives a majority of revenue to the company.

                ---

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                Dechra Pharmaceuticals
                Verona Pharma
                Alliance Pharma
                Indivior
                Redx Pharma

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis